BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11753661)

  • 1. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors.
    Aydinlik H; Nguyen TD; Moennikes O; Buchmann A; Schwarz M
    Oncogene; 2001 Nov; 20(53):7812-6. PubMed ID: 11753661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital.
    Loeppen S; Schneider D; Gaunitz F; Gebhardt R; Kurek R; Buchmann A; Schwarz M
    Cancer Res; 2002 Oct; 62(20):5685-8. PubMed ID: 12384525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor formation in liver of conditional β-catenin-deficient mice exposed to a diethylnitrosamine/phenobarbital tumor promotion regimen.
    Rignall B; Braeuning A; Buchmann A; Schwarz M
    Carcinogenesis; 2011 Jan; 32(1):52-7. PubMed ID: 21047994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of beta-catenin mutation by dietary exposure of auraptene, a citrus antioxidant, in N,N-diethylnitrosamine-induced hepatocellular carcinomas in rats.
    Hara A; Sakata K; Yamada Y; Kuno T; Kitaori N; Oyama T; Hirose Y; Murakami A; Tanaka T; Mori H
    Oncol Rep; 2005 Aug; 14(2):345-51. PubMed ID: 16012713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.
    Calvisi DF; Ladu S; Factor VM; Thorgeirsson SS
    Carcinogenesis; 2004 Jun; 25(6):901-8. PubMed ID: 14742323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of mutant frequencies of chemically induced tumors and normal tissues in lambda/cII transgenic mice.
    Mirsalis JC; Shimon JA; Johnson A; Fairchild D; Kanazawa N; Nguyen T; de Boer J; Glickman B; Winegar RA
    Environ Mol Mutagen; 2005; 45(1):17-35. PubMed ID: 15605353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of connexin32 and beta-catenin in tumor promotion in mouse liver.
    Schwarz M; Wanke I; Wulbrand U; Moennikes O; Buchmann A
    Toxicol Pathol; 2003; 31(1):99-102. PubMed ID: 12597453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A beta-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors.
    Loeppen S; Koehle C; Buchmann A; Schwarz M
    Carcinogenesis; 2005 Jan; 26(1):239-48. PubMed ID: 15471898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice.
    Manam S; Storer RD; Prahalada S; Leander KR; Kraynak AR; Ledwith BJ; van Zwieten MJ; Bradley MO; Nichols WW
    Cancer Res; 1992 Jun; 52(12):3347-52. PubMed ID: 1596892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of mutations at codon 61 of the Ha-ras gene in liver tumors of mice genetically susceptible and resistant to hepatocarcinogenesis.
    Dragani TA; Manenti G; Colombo BM; Falvella FS; Gariboldi M; Pierotti MA; Della Porta G
    Oncogene; 1991 Feb; 6(2):333-8. PubMed ID: 2000226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice.
    Ogawa K; Yamada Y; Kishibe K; Ishizaki K; Tokusashi Y
    Cancer Res; 1999 Apr; 59(8):1830-3. PubMed ID: 10213486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
    Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
    Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane.
    Takahashi M; Nakatsugi S; Sugimura T; Wakabayashi K
    Carcinogenesis; 2000 Jun; 21(6):1117-20. PubMed ID: 10836998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
    Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
    Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis.
    Buchmann A; Karcier Z; Schmid B; Strathmann J; Schwarz M
    Mutat Res; 2008 Feb; 638(1-2):66-74. PubMed ID: 17928010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different frequencies and patterns of beta-catenin mutations in hepatocellular carcinomas induced by N-nitrosodiethylamine and a choline-deficient L-amino acid-defined diet in rats.
    Tsujiuchi T; Tsutsumi M; Sasaki Y; Takahama M; Konishi Y
    Cancer Res; 1999 Aug; 59(16):3904-7. PubMed ID: 10463579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
    Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
    Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice.
    Wang Y; Wang Y; Stoner G; You M
    Cancer Res; 1993 Apr; 53(7):1620-4. PubMed ID: 8453632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis.
    Devereux TR; Anna CH; Foley JF; White CM; Sills RC; Barrett JC
    Oncogene; 1999 Aug; 18(33):4726-33. PubMed ID: 10467420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ha-ras and β-catenin oncoproteins orchestrate metabolic programs in mouse liver tumors.
    Unterberger EB; Eichner J; Wrzodek C; Lempiäinen H; Luisier R; Terranova R; Metzger U; Plummer S; Knorpp T; Braeuning A; Moggs J; Templin MF; Honndorf V; Piotto M; Zell A; Schwarz M
    Int J Cancer; 2014 Oct; 135(7):1574-85. PubMed ID: 24535843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.